StockData
MBody AI Ltd. logo

MBody AI Ltd. (MBAI) stock

MBAINasdaqServices-Computer Integrated Systems Design
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 5/30
$2.08+0.02 (+1.22%)

Close on Nov 16, 2026Market cap $14.60MP/E 3.2Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025

Valuation

Market cap
$14.60M
P/E ratio
3.2
Price to sales
–
Price to book
4.25
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
$4.14M
EPS, diluted
$0.66

Trading

Previous close
$2.06
Open
$2.06
Day's range
$2.02 – $2.08
Volume
7,022
Average volume (20 days)
21,870
52-week range
$1.61 – $27.44
RSI (14 days)
38.1
Volatility (1 year)
153.2%
Relative volume
0.33×

Market cap history

Month-end market cap since 2015, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 16, 2026. The S&P 500 is measured by the SPY fund.

PeriodMBAIS&P 500DifferenceMBAI per yearS&P 500 per year
1 month-24.4%-3.1%−21.3 pts
3 months-76.1%-4.5%−71.7 pts
Year to date-81.7%+9.4%−91.0 pts
1 year-85.0%+11.3%−96.3 pts
3 years-91.8%+70.4%−162.2 pts-56.5%+19.4%
5 years-98.4%+68.6%−167.0 pts-56.1%+11.0%
10 years-100.0%+297.7%−397.6 pts-53.5%+14.8%

Fourteen years at a glance

Fiscal years 2012 to 2025, USD

Operating income

-$2.37M

Net income

$4.14M

EPS, diluted

$0.66

Free cash flow

–
Reported period

Press releases

Releases MBody AI filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About MBody AI

Services-Computer Integrated Systems Design

Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on developing screening technologies for the gastrointestinal tract. Its primary product candidate is C-Scan, an ingestible capsule system comprising the C-Scan Cap, C-Scan Track, and C-Scan View. The system uses imaging alongside an oral contrast agent to detect colorectal abnormalities. Check-Cap designs its diagnostic solutions for patients requiring gastrointestinal screening, alongside physicians and clinical healthcare providers.

Company profile, executives and history

MBody AI stock: common questions

What is MBody AI's stock price?

MBAI closed at $2.08 on Nov 16, 2026, up 1.22% on the day. Over the past 52 weeks it traded between $1.61 and $27.44.

What is MBody AI's market cap?

MBody AI was worth $14.60M at the close on Nov 16, 2026: the share price times the diluted shares outstanding.

What is MBAI's P/E ratio?

MBAI trades at 3.2 times earnings, based on diluted earnings per share of $0.66 over fiscal 2025.

Does MBody AI pay a dividend?

No. MBody AI has not paid a cash dividend over the last twelve months.

How has MBAI stock performed over the past year?

Including dividends, MBAI returned -85.0% over the past year, against +11.3% for the S&P 500.

Who are MBody AI's competitors?

Companies most similar to MBody AI by business, industry and size include ODYS, OMQS, BNAI, ARBE, DAIC.

See a number that looks wrong?